A randomized, double-blind crossover study to investigate the analgesic efficacy of the bradykinin (B2) antagonist icatibant for propofol injection pain in healthy adult participants.
Not yet recruitingCTIS2025-521354-42-00
Oslo University Hospital HFPain
Target: 26Updated: 2025-08-14